Lupin Limited announced that Ms. Christine Mundkur, Independent Director will be stepping down from the Board of Directors of the Company, effective January 1, 2023, to avoid any conflict of interest since she has recently joined the Board of Cardinal Health, USA as an Independent Director.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,605 INR | -0.00% |
|
-0.14% | +21.34% |
06-05 | Lupin Arm Acquires Two Brands from Sanofi in Europe and Canada | MT |
05-30 | India's pharma export sales to grow faster this year, trade body says | RE |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.34% | 8.77B | |
+48.79% | 781B | |
+41.33% | 639B | |
+19.43% | 330B | |
+7.18% | 293B | |
+17.32% | 248B | |
-0.12% | 221B | |
+11.56% | 217B | |
+4.53% | 162B | |
-3.92% | 157B |
- Stock Market
- Equities
- LUPIN Stock
- News Lupin Limited
- Lupin Limited Announces Christine Mundkur Steps Down from Board of Directors, Effective January 1, 2023